The objective of the FLOW trial was to see if Ozempic delayed CKD progression and lowered risk of kidney- and cardiovascular-related death
Non-GLP-1 options: Other weight loss medications, structured programs, or metabolic surgery may be appropriate depending on your situation
The 4 patient group inputs reported that overweight and obesity affect many areas of life and patients usually present with various comorbid conditions, such as arthritis, hypertension, sleep apnea, gastroesophageal reflux disease, irritable bowel syndrome, high cholesterol, diabetes, fatty liver disease, asthma, osteoarthritis, infertility, cancers, and mental health issues
Rybelsus (semaglutide tablets) [package insert]
Florida Surgery and Weight Loss Center helps eligible patients review medical weight loss options, including semaglutide and tirzepatide, when clinically appropriate
Empower Pharmacy specifically chose methylcobalamin for their semaglutide orally disintegrating tablet (ODT)